Testing cold versus room-temperature platelet storage for bleeding
Part of Blood & lymphatic, Cancer clinical trials.
This pilot trial compares whether platelets stored cold or at room temperature work better to control bleeding in adults with blood cancers or marrow failure. It may help find a simpler, safer way to manage bleeding and platelet transfusions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and currently in a hospital unit for blood cancers or marrow aplasia
- Your platelet count is moderately low, around 10 to 100 (10 billion to 100 billion) per liter
- A doctor has ordered a platelet transfusion to treat active bleeding
- Your platelet count is not extremely low (it must be at least 10)
- You do not have special rare platelet problems that require matched (HLA/HPA) platelets
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at platelet transfusions—how they’re used and whether platelets function well—for people with blood cancers who have low platelet counts. It may help improve transfusion care for people who need platelet support.
This trial tests how well platelet transfusions work for patients with blood cancers or bone marrow failure who have very low platelets and need a transfusion. It aims to see if the transfusions help control bleeding and improve outcomes.
This trial studies whether a platelet-related treatment can work better in people in the ICU who need a platelet transfusion after surgery. It may help reduce bleeding by improving how platelets work when certain blood clotting proteins are already high.
This trial compares how platelets are given during a stem cell transplant to help prevent bleeding. It also watches for clotting risks, since platelets can affect both bleeding and clot formation.
This study looks at a new way to predict if patients with blood cancers and very low platelets will have bleeding problems. By doing extra blood tests, researchers hope to create a score that helps doctors prevent bleeds.
This study tests whether giving platelet transfusions to critically ill patients with very low platelet counts helps prevent dangerous bleeding. If you're in the ICU with a very low platelet count, this trial might help decide the best way to keep you safe.
Hear when a new Hematologic Malignancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.